Utilization of Bone-Anchored Annular Defect Closure to Prevent Reherniation Following Lumbar Discectomy: Overcoming Barriers to Clinical Adoption and Market …
MP Lorio, WC Watters, BH Grunch… - International Journal of …, 2024 - ijssurgery.com
While achieving premarket approval from the US Food and Drug Administration represents a
significant milestone in the development and commercialization of a Class III medical …
significant milestone in the development and commercialization of a Class III medical …
Utilization of Bone-Anchored Annular Defect Closure to Prevent Reherniation Following Lumbar Discectomy: Overcoming Barriers to Clinical Adoption and Market …
MP Lorio, WC Watters, BH Grunch… - … journal of spine …, 2024 - pubmed.ncbi.nlm.nih.gov
While achieving premarket approval from the US Food and Drug Administration represents a
significant milestone in the development and commercialization of a Class III medical …
significant milestone in the development and commercialization of a Class III medical …
Utilization of Bone-Anchored Annular Defect Closure to Prevent Reherniation Following Lumbar Discectomy: Overcoming Barriers to Clinical Adoption and Market …
MP Lorio, WC Watters, BH Grunch… - International Journal of …, 2024 - ijssurgery.com
While achieving premarket approval from the US Food and Drug Administration represents a
significant milestone in the development and commercialization of a Class III medical …
significant milestone in the development and commercialization of a Class III medical …
Utilization of Bone-Anchored Annular Defect Closure to Prevent Reherniation Following Lumbar Discectomy: Overcoming Barriers to Clinical Adoption and Market …
MP LORIO, WC WATTERS… - … Journal of Spine …, 2024 - search.ebscohost.com
While achieving premarket approval from the US Food and Drug Administration represents a
significant milestone in the development and commercialization of a Class III medical …
significant milestone in the development and commercialization of a Class III medical …
Utilization of Bone-Anchored Annular Defect Closure to Prevent Reherniation Following Lumbar Discectomy: Overcoming Barriers to Clinical Adoption and Market …
MP Lorio, WC Watters, BH Grunch… - … Journal of Spine …, 2024 - europepmc.org
While achieving premarket approval from the US Food and Drug Administration represents a
significant milestone in the development and commercialization of a Class III medical …
significant milestone in the development and commercialization of a Class III medical …